Health care consequences of black-box warnings for antidepressants in the United States and Canada
To access this article, please choose from the options below
Declaration of interest: The authors have no relevant financial interest to declare. No funding was received for this study.
PII: S1551-7411(09)00045-X
doi:10.1016/j.sapharm.2009.02.005
© 2010 Elsevier Inc. All rights reserved.
